SEATTLE--(BUSINESS WIRE)--MitoPharm Corporation, Inc. (Pinksheets: MTPM), today announced that its founder, Dr. Robert Ko, is introducing a new, commercial – scale process for the extraction of “(-) Schisandrin B” and “Schisandrin B.” The new extraction process is made possible by hybrid chromatography - crystallization technology, which extends the market of the company’s branded product to pharmaceuticals, dietary supplements, functional beverages and commercial grade raw material applications.
